Análisis Argos
HQY
HQYCara
HealthEquity, Inc. · Healthcare
US$ 95.31
precio al 2026-07-04
Valor justo Argos*
US$ 51–57
vs. su valor justo
68% por encima
Score Argos
58/100
LA RESPUESTA
El mercado le pide crezca 27.5% al año — más de lo que ha demostrado (10.3%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
✓Las ganancias crecieron 123% el último año.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
VALOR1/6FUTURO4/6PASADO4/6SALUD3/6DIVIDENDO4/6
El Iris de calidad
VALOR1/6FUTURO4/6PASADO4/6SALUD3/6DIVIDENDO4/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoFundamentales sólidos y sostenidos
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos58de 100Cara
Ingresos▲9%
US$ 1.3 B
Margen operativo▲28%
24.6%
Flujo de caja libre▲35%
US$ 0.5 B
Deuda neta
US$ 0.7 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 8.0B
P/E37x
EV/EBITDA18.1x
FCF yield5.7%
ROIC9%
Margen operativo24.6%
Crecim. ingresos+9.5%/año
Piotroski F9/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 19 jun
Here's Why HealthEquity (HQY) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com · 12 jun
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.
zacks.com · 11 jun
Is HealthEquity's Improving Profitability Enough to Offset Key Risks?
HQY raises fiscal 2027 guidance after strong Q1 results, but custodial yield swings and cybersecurity worries remain.
globenewswire.com · 8 jun
One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds
Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control
zacks.com · 8 jun
3 Medical Service Industry Stocks Thriving Amid Workforce Challenges
BTSG, BDSX and HQY stand to benefit as digital health, healthcare analytics and nursing care growth offset workforce strains.
zacks.com · 4 jun
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
zacks.com · 4 jun
Wall Street Analysts See a 33.49% Upside in HealthEquity (HQY): Can the Stock Really Move This High?
The consensus price target hints at a 33.5% upside potential for HealthEquity (HQY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
zacks.com · 4 jun
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.